Funding Available for PCSK9-Related Research

The 2nd annual Pfizer ASPIRE Cardiovascular Grants Program offers individual grants from a total fund of US $2 million — Apply now! 

Are you or any of your collaborators involved in PCSK9-related research and looking for funding to support your work?

Click here for further details on ASPIRE Cardiovascular, a Pfizer-supported independent competitive grants program awarding individual grants of up to US $200,000 from a total fund of US $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.

Application deadline: March 13, 2016